Cargando…

Risk factors for cardiovascular disease among individuals with hepatic steatosis

Cardiovascular disease (CVD) is the leading cause of mortality in adults with hepatic steatosis (HS). However, risk factors for CVD in HS are unknown. We aimed to identify factors associated with coronary artery disease (CAD) and incident major adverse cardiovascular events (MACE) in individuals wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Karády, Julia, Ferencik, Maros, Mayrhofer, Thomas, Meyersohn, Nandini M., Bittner, Daniel O., Staziaki, Pedro V., Szilveszter, Balint, Hallett, Travis R., Lu, Michael T., Puchner, Stefan B., Simon, Tracey G., Foldyna, Borek, Ginsburg, Geoffrey S., McGarrah, Robert W., Voora, Deepak, Shah, Svati H., Douglas, Pamela S., Hoffmann, Udo, Corey, Kathleen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701472/
https://www.ncbi.nlm.nih.gov/pubmed/36281983
http://dx.doi.org/10.1002/hep4.2090
_version_ 1784839542815064064
author Karády, Julia
Ferencik, Maros
Mayrhofer, Thomas
Meyersohn, Nandini M.
Bittner, Daniel O.
Staziaki, Pedro V.
Szilveszter, Balint
Hallett, Travis R.
Lu, Michael T.
Puchner, Stefan B.
Simon, Tracey G.
Foldyna, Borek
Ginsburg, Geoffrey S.
McGarrah, Robert W.
Voora, Deepak
Shah, Svati H.
Douglas, Pamela S.
Hoffmann, Udo
Corey, Kathleen E.
author_facet Karády, Julia
Ferencik, Maros
Mayrhofer, Thomas
Meyersohn, Nandini M.
Bittner, Daniel O.
Staziaki, Pedro V.
Szilveszter, Balint
Hallett, Travis R.
Lu, Michael T.
Puchner, Stefan B.
Simon, Tracey G.
Foldyna, Borek
Ginsburg, Geoffrey S.
McGarrah, Robert W.
Voora, Deepak
Shah, Svati H.
Douglas, Pamela S.
Hoffmann, Udo
Corey, Kathleen E.
author_sort Karády, Julia
collection PubMed
description Cardiovascular disease (CVD) is the leading cause of mortality in adults with hepatic steatosis (HS). However, risk factors for CVD in HS are unknown. We aimed to identify factors associated with coronary artery disease (CAD) and incident major adverse cardiovascular events (MACE) in individuals with HS. We performed a nested cohort study of adults with HS detected on coronary computed tomography in the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial. Obstructive CAD was defined as ≥50% coronary stenosis. MACE included hospitalization for unstable angina, nonfatal myocardial infarction, or all‐cause death. Multivariate modeling, adjusted for age, sex, atherosclerotic CVD (ASCVD) risk score and body mass index, identified factors associated with obstructive CAD. Cox regression, adjusted for ASCVD risk score, determined the predictors of MACE. A total of 959 of 3,756 (mean age 59.4 years, 55.0% men) had HS. Obstructive CAD was present in 15.2% (145 of 959). Male sex (adjusted odds ratio [aOR] = 1.83, 95% confidence interval [CI] 1.18–1.2.84; p = 0.007), ASCVD risk score (aOR = 1.05, 95% CI 1.03–1.07; p < 0.001), and n‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP; aOR = 1.90, 95% CI 1.38–2.62; p < 0.001) were independently associated with obstructive CAD. In the 25‐months median follow‐up, MACE occurred in 4.4% (42 of 959). Sedentary lifestyle (adjusted hazard ratio [aHR] = 2.53, 95% CI 1.27–5.03; p = 0.008) and NT‐proBNP (aOR = 1.50, 95% CI 1.01–2.25; p = 0.046) independently predicted MACE. Furthermore, the risk of MACE increased by 3% for every 1% increase in ASCVD risk score (aHR = 1.03, 95% CI 1.01–1.05; p = 0.02). Conclusion: In individuals with HS, male sex, NT‐pro‐BNP, and ASCVD risk score are associated with obstructive CAD. Furthermore, ASCVD, NT‐proBNP, and sedentary lifestyle are independent predictors of MACE. These factors, with further validation, may help risk‐stratify adults with HS for incident CAD and MACE.
format Online
Article
Text
id pubmed-9701472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97014722022-11-28 Risk factors for cardiovascular disease among individuals with hepatic steatosis Karády, Julia Ferencik, Maros Mayrhofer, Thomas Meyersohn, Nandini M. Bittner, Daniel O. Staziaki, Pedro V. Szilveszter, Balint Hallett, Travis R. Lu, Michael T. Puchner, Stefan B. Simon, Tracey G. Foldyna, Borek Ginsburg, Geoffrey S. McGarrah, Robert W. Voora, Deepak Shah, Svati H. Douglas, Pamela S. Hoffmann, Udo Corey, Kathleen E. Hepatol Commun Original Articles Cardiovascular disease (CVD) is the leading cause of mortality in adults with hepatic steatosis (HS). However, risk factors for CVD in HS are unknown. We aimed to identify factors associated with coronary artery disease (CAD) and incident major adverse cardiovascular events (MACE) in individuals with HS. We performed a nested cohort study of adults with HS detected on coronary computed tomography in the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial. Obstructive CAD was defined as ≥50% coronary stenosis. MACE included hospitalization for unstable angina, nonfatal myocardial infarction, or all‐cause death. Multivariate modeling, adjusted for age, sex, atherosclerotic CVD (ASCVD) risk score and body mass index, identified factors associated with obstructive CAD. Cox regression, adjusted for ASCVD risk score, determined the predictors of MACE. A total of 959 of 3,756 (mean age 59.4 years, 55.0% men) had HS. Obstructive CAD was present in 15.2% (145 of 959). Male sex (adjusted odds ratio [aOR] = 1.83, 95% confidence interval [CI] 1.18–1.2.84; p = 0.007), ASCVD risk score (aOR = 1.05, 95% CI 1.03–1.07; p < 0.001), and n‐terminal pro‐b‐type natriuretic peptide (NT‐proBNP; aOR = 1.90, 95% CI 1.38–2.62; p < 0.001) were independently associated with obstructive CAD. In the 25‐months median follow‐up, MACE occurred in 4.4% (42 of 959). Sedentary lifestyle (adjusted hazard ratio [aHR] = 2.53, 95% CI 1.27–5.03; p = 0.008) and NT‐proBNP (aOR = 1.50, 95% CI 1.01–2.25; p = 0.046) independently predicted MACE. Furthermore, the risk of MACE increased by 3% for every 1% increase in ASCVD risk score (aHR = 1.03, 95% CI 1.01–1.05; p = 0.02). Conclusion: In individuals with HS, male sex, NT‐pro‐BNP, and ASCVD risk score are associated with obstructive CAD. Furthermore, ASCVD, NT‐proBNP, and sedentary lifestyle are independent predictors of MACE. These factors, with further validation, may help risk‐stratify adults with HS for incident CAD and MACE. John Wiley and Sons Inc. 2022-10-25 /pmc/articles/PMC9701472/ /pubmed/36281983 http://dx.doi.org/10.1002/hep4.2090 Text en © 2022 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Karády, Julia
Ferencik, Maros
Mayrhofer, Thomas
Meyersohn, Nandini M.
Bittner, Daniel O.
Staziaki, Pedro V.
Szilveszter, Balint
Hallett, Travis R.
Lu, Michael T.
Puchner, Stefan B.
Simon, Tracey G.
Foldyna, Borek
Ginsburg, Geoffrey S.
McGarrah, Robert W.
Voora, Deepak
Shah, Svati H.
Douglas, Pamela S.
Hoffmann, Udo
Corey, Kathleen E.
Risk factors for cardiovascular disease among individuals with hepatic steatosis
title Risk factors for cardiovascular disease among individuals with hepatic steatosis
title_full Risk factors for cardiovascular disease among individuals with hepatic steatosis
title_fullStr Risk factors for cardiovascular disease among individuals with hepatic steatosis
title_full_unstemmed Risk factors for cardiovascular disease among individuals with hepatic steatosis
title_short Risk factors for cardiovascular disease among individuals with hepatic steatosis
title_sort risk factors for cardiovascular disease among individuals with hepatic steatosis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701472/
https://www.ncbi.nlm.nih.gov/pubmed/36281983
http://dx.doi.org/10.1002/hep4.2090
work_keys_str_mv AT karadyjulia riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT ferencikmaros riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT mayrhoferthomas riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT meyersohnnandinim riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT bittnerdanielo riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT staziakipedrov riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT szilveszterbalint riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT halletttravisr riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT lumichaelt riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT puchnerstefanb riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT simontraceyg riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT foldynaborek riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT ginsburggeoffreys riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT mcgarrahrobertw riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT vooradeepak riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT shahsvatih riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT douglaspamelas riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT hoffmannudo riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis
AT coreykathleene riskfactorsforcardiovasculardiseaseamongindividualswithhepaticsteatosis